BBS-Bioactive Bone Substitutes (BBS) is a biomedical technology company developing innovative, biologically active medical device implants to be used in orthopedic surgery.
Our first product, ARTEBONE®, is made from a natural animal source of bone material that has a superior capability of bone regeneration compared to existing products.
Employees: 11-50
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | Innovestor | innovestor... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 18.12.2023 | BBS-Bioactive Bone Substitutes Plc’s rights issue raised gro... | - | globenewsw... |
| 03.07.2023 | BBS-Bioactive Bone Substitutes Plc: BBS-Bioactive Bone Subst... | - | globenewsw... |
| 07.06.2023 | BBS-Bioactive Bone Substitutes Plc: 57% of warrants 2-2022 (... | - | globenewsw... |
| 09.12.2022 | BBS-Bioactive Bone Substitutes: 69% of the warrants 1-2022 (... | - | globenewsw... |
| 26.05.2020 | BBS-BIOACTIVE BONE SUBSTITUTES OYJ BBS-Bioactive Bone Subst... | Company Announcement, Insider information 26 May 2020 at 2:00 pm (UTC +3.00). The Board of Director... | marketscre... |